Greenwich LifeSciences, Inc.GLSINASDAQ
LOADING
|||
Cash Flow Performance
Below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-4.97%
↓ 158% below average
Average (7y)
-1.93%
Historical baseline
Range
High:-0.19%
Low:-4.97%
CAGR
+57.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -4.97% | -3.7% |
| 2023 | -4.79% | -51.8% |
| 2022 | -3.16% | -131.8% |
| 2021 | -1.36% | -447.6% |
| 2020 | -0.25% | +50.2% |
| 2019 | -0.50% | -160.0% |
| 2018 | -0.19% | +6.7% |
| 2017 | -0.21% | - |